Pat Cotroneo
2014
In 2014, Pat Cotroneo earned a total compensation of $2.9M as Chief Financial Officer at FibroGen, a 345% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $450,088 |
|---|---|
| Option Awards | $1,577,772 |
| Salary | $377,438 |
| Stock Awards | $504,000 |
| Other | $16,364 |
| Total | $2,925,662 |
Cotroneo received $1.6M in option awards, accounting for 54% of the total pay in 2014.
Cotroneo also received $450.1K in non-equity incentive plan, $377.4K in salary, $504K in stock awards and $16.4K in other compensation.
Rankings
In 2014, Pat Cotroneo's compensation ranked 3,104th out of 13,032 executives tracked by ExecPay. In other words, Cotroneo earned more than 76.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,104 out of 13,032 | 76th |
Division Manufacturing | 1,101 out of 4,965 | 78th |
Major group Chemicals And Allied Products | 353 out of 1,690 | 79th |
Industry group Drugs | 276 out of 1,369 | 80th |
Industry Pharmaceutical Preparations | 225 out of 1,042 | 78th |
Source: SEC filing on April 24, 2017.
Cotroneo's colleagues
We found three more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2014.